| 1.0 |
5.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.7 |
2.1 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.6 |
2.6 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.6 |
4.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.5 |
1.5 |
GO:0030264 |
nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.5 |
3.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 |
2.0 |
GO:0009183 |
purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.5 |
2.8 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.5 |
2.3 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 |
1.3 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.4 |
0.4 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 |
3.2 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.4 |
1.2 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.4 |
1.1 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.4 |
3.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.4 |
1.5 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 |
1.5 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.4 |
1.1 |
GO:2000521 |
negative regulation of immunological synapse formation(GO:2000521) |
| 0.4 |
1.1 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.3 |
1.0 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.3 |
1.0 |
GO:1990619 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
| 0.3 |
0.7 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.3 |
1.0 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.3 |
1.0 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 |
1.0 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.3 |
1.3 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.3 |
0.9 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.3 |
1.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.3 |
2.4 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 |
0.3 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.3 |
0.9 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.3 |
0.6 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.3 |
1.2 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 |
1.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
1.4 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.3 |
1.1 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.3 |
0.8 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.3 |
1.7 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.3 |
1.4 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.3 |
2.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.3 |
0.8 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.3 |
0.8 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.3 |
1.1 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.3 |
1.0 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.3 |
0.8 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.3 |
0.8 |
GO:2000364 |
regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.3 |
0.8 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.3 |
1.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
0.5 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
0.3 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.2 |
0.5 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 |
1.0 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.2 |
0.7 |
GO:0018194 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 |
0.7 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.2 |
1.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
2.6 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.2 |
1.2 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
0.9 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.2 |
0.9 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 |
1.8 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
1.1 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
0.9 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
1.3 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 |
2.9 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
0.2 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.2 |
0.7 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 |
0.6 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.2 |
0.6 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.2 |
0.8 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 |
0.6 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.2 |
0.4 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 |
1.2 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.2 |
1.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
0.8 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 |
0.8 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.2 |
3.0 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.2 |
0.6 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 |
0.2 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) |
| 0.2 |
0.2 |
GO:0048144 |
fibroblast proliferation(GO:0048144) |
| 0.2 |
0.6 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 |
0.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.8 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
0.8 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
1.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
1.5 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 |
0.9 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.2 |
1.5 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
0.7 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.9 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
0.4 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.2 |
0.7 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
1.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
6.6 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.7 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.2 |
1.2 |
GO:0036343 |
psychomotor behavior(GO:0036343) |
| 0.2 |
0.7 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 |
0.3 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.2 |
0.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
1.3 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 |
0.7 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.2 |
0.5 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.2 |
1.0 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.2 |
0.6 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 |
0.6 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.2 |
0.5 |
GO:2000612 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 |
0.8 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
1.3 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.2 |
0.8 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
2.2 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.2 |
0.3 |
GO:0048597 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.2 |
0.5 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 |
0.9 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
1.4 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
0.5 |
GO:1904875 |
regulation of DNA ligase activity(GO:1904875) |
| 0.2 |
0.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
1.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.6 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.2 |
0.5 |
GO:0070229 |
negative regulation of lymphocyte apoptotic process(GO:0070229) |
| 0.2 |
0.5 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.2 |
1.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
1.3 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 |
0.7 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.1 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.6 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.1 |
0.9 |
GO:2000538 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.1 |
1.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
3.6 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.7 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.1 |
0.6 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.1 |
0.4 |
GO:0060532 |
bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.1 |
1.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.6 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
1.0 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.6 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.1 |
1.0 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.3 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 |
0.8 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.6 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
0.1 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.1 |
0.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
0.3 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.1 |
0.4 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.1 |
0.7 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.1 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.7 |
GO:0090182 |
regulation of secretion of lysosomal enzymes(GO:0090182) |
| 0.1 |
0.3 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.4 |
GO:0021938 |
ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.1 |
0.3 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.1 |
0.9 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.3 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 |
0.7 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.1 |
GO:2000722 |
regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) |
| 0.1 |
1.6 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
1.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
1.3 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 |
0.4 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.1 |
1.4 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
4.0 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
1.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.8 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
0.4 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.9 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.5 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.1 |
0.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.8 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.1 |
0.6 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
0.5 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.9 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.5 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 |
0.7 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
0.5 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.1 |
0.6 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.5 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.6 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.1 |
0.2 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.1 |
0.5 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.1 |
0.9 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.8 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.1 |
1.0 |
GO:0033088 |
regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
0.8 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.7 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.5 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.3 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 |
0.3 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.1 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.3 |
GO:0032900 |
negative regulation of neurotrophin production(GO:0032900) |
| 0.1 |
0.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.2 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 |
1.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.1 |
0.9 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.7 |
GO:1990668 |
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.9 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
0.5 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.3 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.1 |
0.3 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.1 |
0.3 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 |
0.2 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
2.5 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.6 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 |
0.4 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.3 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.1 |
0.6 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.1 |
GO:0052047 |
interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.1 |
0.4 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 |
0.4 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.1 |
0.7 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
0.7 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.9 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.2 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.6 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.3 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.1 |
0.4 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
0.2 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.1 |
1.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.6 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
2.7 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.3 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.1 |
0.1 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 |
0.1 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.8 |
GO:0002005 |
angiotensin catabolic process in blood(GO:0002005) |
| 0.1 |
0.3 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.1 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 |
0.4 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.4 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.1 |
0.3 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
0.2 |
GO:0043588 |
skin development(GO:0043588) |
| 0.1 |
0.7 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.1 |
0.9 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.1 |
0.8 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.1 |
1.9 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.1 |
GO:0061549 |
sympathetic ganglion development(GO:0061549) |
| 0.1 |
1.3 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.1 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.1 |
0.7 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.5 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.5 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.3 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.4 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.4 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 |
0.9 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.1 |
GO:0046621 |
negative regulation of organ growth(GO:0046621) |
| 0.1 |
0.3 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.1 |
0.3 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
0.9 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.1 |
0.2 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
0.4 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.5 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 |
0.3 |
GO:1990575 |
mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 0.1 |
1.6 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
1.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.1 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
0.6 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.7 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.3 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
0.4 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.8 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.6 |
GO:0009155 |
purine deoxyribonucleotide catabolic process(GO:0009155) |
| 0.1 |
0.3 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.1 |
0.4 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.2 |
GO:0030705 |
cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.1 |
1.0 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.4 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 |
1.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
2.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.2 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
0.5 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 |
3.0 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 |
0.7 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
1.1 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.2 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.2 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.1 |
0.2 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.1 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.2 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 |
0.2 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.1 |
1.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.9 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.5 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
1.0 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
0.1 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
0.1 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.2 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
1.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 |
0.4 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
0.6 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.2 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.1 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.2 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.1 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
| 0.1 |
0.2 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
0.4 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 |
0.1 |
GO:0002715 |
regulation of natural killer cell mediated immunity(GO:0002715) |
| 0.1 |
0.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.8 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.1 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.2 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 |
0.1 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.1 |
0.6 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.6 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.3 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
0.4 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 |
0.8 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.1 |
0.8 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.1 |
0.2 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 |
0.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.4 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.7 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
1.2 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.1 |
0.6 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.2 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.1 |
GO:0030177 |
positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.1 |
0.3 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.1 |
0.8 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
| 0.1 |
0.5 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.1 |
GO:1901856 |
negative regulation of oxidative phosphorylation(GO:0090324) negative regulation of cellular respiration(GO:1901856) regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 |
1.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.9 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.2 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 |
0.1 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
0.2 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.1 |
0.1 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.1 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.1 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 |
0.1 |
GO:0072193 |
ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.1 |
0.4 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
0.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
1.6 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
0.3 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
0.2 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 |
0.2 |
GO:0071651 |
chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.1 |
0.3 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.1 |
0.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 |
0.7 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.3 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.1 |
0.2 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
0.1 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.1 |
0.2 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 |
0.3 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.2 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.5 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.2 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.1 |
1.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.6 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.3 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) |
| 0.1 |
0.2 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.1 |
0.2 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.1 |
0.5 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.2 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
0.5 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.7 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.4 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
1.1 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.5 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
1.3 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
0.6 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.8 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.1 |
0.2 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.2 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
0.1 |
GO:0032431 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 0.1 |
0.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.2 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.1 |
0.2 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 |
1.0 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.6 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.1 |
0.7 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.2 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
0.1 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
0.4 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.1 |
0.3 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.4 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
0.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.3 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.1 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
1.0 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.2 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.4 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.2 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.3 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.2 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.1 |
0.5 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.2 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.2 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
0.2 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.1 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
0.3 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.1 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.1 |
0.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.2 |
GO:1903517 |
regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.1 |
0.8 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.3 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.4 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.4 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
0.2 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.1 |
0.3 |
GO:0010042 |
response to manganese ion(GO:0010042) |
| 0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.2 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.1 |
0.1 |
GO:0052572 |
response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 0.1 |
0.1 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.0 |
0.2 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.1 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.1 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.0 |
0.1 |
GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.1 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.0 |
0.3 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.0 |
1.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.0 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
0.1 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
1.2 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.1 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.0 |
0.1 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.0 |
0.3 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.0 |
0.1 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.0 |
0.1 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.0 |
0.2 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 |
1.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.1 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.2 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.0 |
0.0 |
GO:2000725 |
regulation of cardiac muscle cell differentiation(GO:2000725) |
| 0.0 |
0.1 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 |
0.2 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.5 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
1.1 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 |
0.0 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.0 |
0.5 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.6 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
1.3 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.0 |
0.8 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.0 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
0.1 |
GO:0043181 |
sucrose metabolic process(GO:0005985) vacuolar sequestering(GO:0043181) |
| 0.0 |
0.4 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 |
0.1 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.0 |
0.3 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.4 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
0.0 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.3 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.0 |
0.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.2 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.2 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.0 |
0.2 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.1 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.0 |
0.1 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.0 |
1.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.2 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.0 |
0.2 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 |
0.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.2 |
GO:0034377 |
plasma lipoprotein particle assembly(GO:0034377) |
| 0.0 |
1.5 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 |
0.7 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.4 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.3 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.3 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.1 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.1 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.1 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.0 |
0.3 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.0 |
0.0 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.0 |
1.3 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.7 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.3 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.1 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.0 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 |
0.1 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.0 |
0.3 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 |
0.1 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.0 |
0.1 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.0 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.0 |
0.5 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
2.0 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.0 |
GO:0072132 |
mesenchyme morphogenesis(GO:0072132) |
| 0.0 |
0.4 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 |
0.5 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.7 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.4 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.0 |
3.5 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.4 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
0.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.4 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.4 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.0 |
0.1 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.0 |
0.2 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 |
0.1 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.0 |
0.2 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.0 |
0.2 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.0 |
0.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.0 |
0.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.8 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.6 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.1 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.0 |
0.8 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
1.7 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.2 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 |
0.3 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
0.1 |
GO:0040036 |
regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.0 |
0.2 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
0.1 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.0 |
0.5 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.0 |
0.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.3 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.0 |
0.5 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.0 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.0 |
0.1 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.0 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.0 |
0.2 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.3 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.4 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.6 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.0 |
0.0 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.0 |
0.7 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.0 |
0.4 |
GO:1904378 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.3 |
GO:0046782 |
regulation of viral transcription(GO:0046782) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.3 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.1 |
GO:0034971 |
histone H3-R17 methylation(GO:0034971) |
| 0.0 |
0.3 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.5 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.1 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.0 |
0.1 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.0 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.6 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.0 |
0.2 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 |
1.0 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.0 |
0.6 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.2 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.0 |
0.1 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.2 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.2 |
GO:0033081 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.1 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.0 |
0.1 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.0 |
0.3 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.2 |
GO:2000330 |
positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.0 |
0.2 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.0 |
0.2 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.2 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.0 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.2 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.4 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.0 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 |
0.2 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.4 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.6 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.3 |
GO:0035136 |
embryonic forelimb morphogenesis(GO:0035115) forelimb morphogenesis(GO:0035136) |
| 0.0 |
0.7 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.1 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.0 |
0.2 |
GO:1902460 |
transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.0 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.2 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.0 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.1 |
GO:0072254 |
metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
| 0.0 |
0.6 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.0 |
0.8 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.4 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.6 |
GO:0048247 |
lymphocyte chemotaxis(GO:0048247) |
| 0.0 |
0.1 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.0 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.5 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.0 |
0.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.2 |
GO:1902093 |
positive regulation of sperm motility(GO:1902093) |
| 0.0 |
0.6 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.0 |
0.1 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.0 |
0.1 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.0 |
0.1 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.1 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.1 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.1 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 |
0.2 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.7 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.4 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.1 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
1.0 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.3 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 |
0.1 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.0 |
2.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.1 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.6 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.0 |
0.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.3 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.2 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.1 |
GO:2000471 |
regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 0.0 |
0.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.1 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.2 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.1 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.0 |
0.5 |
GO:0043578 |
nuclear matrix organization(GO:0043578) |
| 0.0 |
0.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.4 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.1 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.0 |
0.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
0.1 |
GO:0015822 |
mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.0 |
0.2 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.0 |
0.2 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.0 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.4 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.1 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 0.0 |
0.6 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.0 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.0 |
0.4 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.2 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.7 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.1 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.1 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.2 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.5 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.7 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
0.1 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.0 |
0.1 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.1 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.9 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.1 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.1 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.0 |
0.0 |
GO:2001252 |
positive regulation of chromosome organization(GO:2001252) |
| 0.0 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.0 |
0.1 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.0 |
0.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.0 |
0.1 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.2 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.0 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.9 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.1 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.0 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.0 |
0.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.0 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.0 |
0.6 |
GO:0034204 |
lipid translocation(GO:0034204) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.1 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.0 |
0.0 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.0 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.0 |
0.1 |
GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 |
0.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.1 |
GO:0046498 |
S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.0 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.0 |
0.0 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.0 |
0.1 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.1 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.0 |
0.1 |
GO:1904029 |
regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.0 |
0.3 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.0 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.0 |
0.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.1 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.0 |
0.3 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.0 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.0 |
0.6 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 |
0.8 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.1 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.3 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.0 |
0.2 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.1 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
1.4 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.0 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.2 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.0 |
0.2 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.0 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.5 |
GO:0097369 |
sodium ion import(GO:0097369) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.2 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.0 |
GO:0003094 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.0 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.2 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.0 |
1.9 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.0 |
2.2 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.2 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.1 |
GO:0048075 |
regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
| 0.0 |
0.1 |
GO:0031294 |
lymphocyte costimulation(GO:0031294) |
| 0.0 |
0.3 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.1 |
GO:2000672 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.0 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.0 |
0.1 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.0 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.0 |
0.0 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0051598 |
meiotic recombination checkpoint(GO:0051598) |
| 0.0 |
0.0 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.0 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.0 |
0.0 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 |
0.1 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.0 |
0.5 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.0 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.0 |
0.1 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
1.8 |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 |
0.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
0.1 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.0 |
0.4 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.0 |
1.8 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.1 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
0.3 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.0 |
0.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.3 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.1 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.0 |
0.1 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.0 |
0.1 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.2 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.3 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.4 |
GO:0045736 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 |
0.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.0 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.1 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 |
0.2 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 |
0.0 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.0 |
0.3 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.0 |
0.9 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.0 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.0 |
0.2 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 |
0.3 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.0 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.0 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
1.5 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.0 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.0 |
0.0 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.0 |
0.0 |
GO:0072506 |
phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
| 0.0 |
0.1 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.0 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.0 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.0 |
0.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.0 |
0.1 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.2 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.1 |
GO:0048865 |
stem cell fate commitment(GO:0048865) |
| 0.0 |
0.1 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0060315 |
negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 |
0.1 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) |
| 0.0 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.1 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 |
0.0 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 |
0.0 |
GO:1902667 |
regulation of axon guidance(GO:1902667) |
| 0.0 |
0.2 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.1 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 |
0.0 |
GO:0030805 |
regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.0 |
0.2 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.1 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 |
0.3 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.0 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.0 |
0.0 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 0.0 |
0.7 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.5 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.0 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.0 |
0.0 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.0 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.0 |
0.1 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 |
0.4 |
GO:0060674 |
placenta blood vessel development(GO:0060674) |
| 0.0 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.0 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.0 |
0.0 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.0 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.0 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.6 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.0 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.1 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.0 |
0.4 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.0 |
GO:0042407 |
inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
| 0.0 |
1.1 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.0 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.0 |
0.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.0 |
0.5 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.0 |
GO:0007595 |
lactation(GO:0007595) |
| 0.0 |
0.5 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.1 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.0 |
0.0 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.1 |
GO:0006306 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 |
0.0 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.0 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 |
0.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.0 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.0 |
0.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.1 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.0 |
0.1 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.1 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.1 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.2 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.0 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.3 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.0 |
0.0 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.0 |
0.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.3 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.1 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.0 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
0.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.0 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 |
0.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
1.5 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.0 |
0.0 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.0 |
0.0 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.0 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.0 |
0.0 |
GO:0019442 |
tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.0 |
0.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.0 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.0 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.1 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.0 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.0 |
0.0 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.0 |
0.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.0 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.0 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.0 |
1.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.1 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.0 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.1 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.0 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.0 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.4 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.0 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
| 0.0 |
0.5 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) |
| 0.0 |
0.1 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.0 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 |
0.0 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.1 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 0.0 |
0.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.0 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 0.0 |
0.1 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.0 |
0.2 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.0 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
0.0 |
GO:0021766 |
limbic system development(GO:0021761) hippocampus development(GO:0021766) |
| 0.0 |
0.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.0 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 |
0.0 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.1 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.9 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.0 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.0 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.0 |
0.1 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 |
0.1 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 |
0.0 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 |
0.2 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
0.2 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
